Kevin C. Sagara - 01 Mar 2025 Form 3 Insider Report for SEMPRA (SRE)

Role
Director
Signature
KEVIN C. SAGARA BY: James M. Spira, Associate General Counsel of Sempra and Attorney-In-Fact
Issuer symbol
SRE
Transactions as of
01 Mar 2025
Net transactions value
$0
Form type
3
Filing time
05 Mar 2025, 20:03:32 UTC
Previous filing
22 Feb 2023
Next filing
17 Mar 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding SRE Common Stock 44,339 01 Mar 2025 Direct
holding SRE Common Stock 2,362 01 Mar 2025 401(k) savings plan (3/1/2025)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding SRE Phantom Shares 01 Mar 2025 Common Stock 1,344 Direct F1, F2, F3, F4
holding SRE Employee Stock Option (right to buy) 01 Mar 2025 Common Stock 67,052 $61.90 Direct F2, F5
holding SRE Employee Stock Option (right to buy) 01 Mar 2025 Common Stock 72,794 $66.00 Direct F2, F5
holding SRE Employee Stock Option (right to buy) 01 Mar 2025 Common Stock 42,680 $76.86 Direct F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Phantom shares of Sempra Common Stock acquired under Sempra's deferred compensation plan. Total includes additional shares accrued as dividend equivalents since the date of the last report of phantom shares.
F2 Date Exercisable is Immediate.
F3 Expiration Date is Not Applicable.
F4 Conversion of Derivative Security is 1 for 1.
F5 Employee stock options granted while director was previously an officer of Sempra.
F6 Date exercisable is immediate with respect to 28,454 shares; the remaining 14,226 shares subject to the stock option will become exercisable on 01/03/2026.